SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN ^® , induces robust humoral and cellular immunity in mice and non-human primates.

Autor: Alimohammadi R; Department of Immunology, ReNAP Therapeutics, Tehran, Iran., Porgoo M; Department of Process Engineering, ReNAP Therapeutics, Tehran, Iran., Eftekhary M; Department of Quality Control, ReNAP Therapeutics, Tehran, Iran., Kiaie SH; Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran., Ansari Dezfouli E; Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran., Dehghani M; Department of Process Engineering, ReNAP Therapeutics, Tehran, Iran., Nasrollahi K; Department of Genetic Engineering, ReNAP Therapeutics, Tehran, Iran., Malekshahabi T; Department of Genetic Engineering, ReNAP Therapeutics, Tehran, Iran., Heidari M; Department of Immunology, ReNAP Therapeutics, Tehran, Iran., Pouya S; Department of Immunology, ReNAP Therapeutics, Tehran, Iran., Alimohammadi M; Department of Immunology, ReNAP Therapeutics, Tehran, Iran., Sattari Khavas D; Department of Engineering, ReNAP Therapeutics, Tehran, Iran., Modaresi MS; Department of Genetic Engineering, ReNAP Therapeutics, Tehran, Iran., Ghasemi MH; Department of Process Engineering, ReNAP Therapeutics, Tehran, Iran., Ramyar H; Department of Process Engineering, ReNAP Therapeutics, Tehran, Iran., Mohammadipour F; Department of Quality Control, ReNAP Therapeutics, Tehran, Iran., Hamzelouei F; Department of Quality Assurance, ReNAP Therapeutics, Tehran, Iran., Mofayezi A; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Mottaghi SS; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Rahmati A; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Razzaznian M; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Tirandazi V; Department of Quality Control, ReNAP Therapeutics, Tehran, Iran., Tat M; Department of Genetic Engineering, ReNAP Therapeutics, Tehran, Iran., Borzouee F; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Sadeghi H; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Haji Mohammadi M; Department of Chemistry, ReNAP Therapeutics, Tehran, Iran., Rastegar L; Department of Chemistry, ReNAP Therapeutics, Tehran, Iran., Safar Sajadi SM; Department of Chemistry, ReNAP Therapeutics, Tehran, Iran., Ehsanbakhsh H; Department of Process Engineering, ReNAP Therapeutics, Tehran, Iran., Bazmbar H; Department of Process Engineering, ReNAP Therapeutics, Tehran, Iran., Baghernejadan Z; Department of Immunology, ReNAP Therapeutics, Tehran, Iran., Shams Nouraei M; Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran., Pazooki P; Department of Quality Control, ReNAP Therapeutics, Tehran, Iran., Pahlavanneshan M; Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran., Alishah K; Department of Genetic Engineering, ReNAP Therapeutics, Tehran, Iran., Nasiri F; Department of Quality Control, ReNAP Therapeutics, Tehran, Iran., Mokhberian N; Department of Quality Control, ReNAP Therapeutics, Tehran, Iran., Mohammadi SS; Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran., Akar S; Rizsamaneh Behboud Darman, Mashhad Medical Technologies Science Park, Mashhad, Iran., Niknam H; Rizsamaneh Behboud Darman, Mashhad Medical Technologies Science Park, Mashhad, Iran., Azizi M; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Ajoudanian M; Department of Engineering, ReNAP Therapeutics, Tehran, Iran., Moteallehi-Ardakani MH; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Mousavi Shaegh SA; Rizsamaneh Behboud Darman, Mashhad Medical Technologies Science Park, Mashhad, Iran.; Laboratory of Microfluidics and Medical Microsystems, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran., Ramezani R; Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran.; Department of Family Therapy, Women Research Center, Alzahra University, Tehran, Iran., Salimi V; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Moazzami R; Department of Protein Engineering, ReNAP Therapeutics, Tehran, Iran., Hashemi SM; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Dehghanizadeh S; ReNAP Therapeutics, Tehran, Iran. s.dehghanizadeh@renap.ir., Khoddami V; ReNAP Therapeutics, Tehran, Iran. v.khoddami@renap.ir.; Pediatric Cell and Gene Therapy Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. v.khoddami@renap.ir.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Sep 02; Vol. 7 (1), pp. 105. Date of Electronic Publication: 2022 Sep 02.